Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BLU-451 |
| Synonyms | |
| Therapy Description |
BLU-451 is a blood-brain-barrier penetrant, mutant-selective, EGFR inhibitor with activity against exon 20 insertions, which blocks downstream signaling potentially resulting in decreased tumor growth (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BLU-451 | BLU451|BLU 451|LNG-451|LNG451|LNG 451 | EGFR Exon 20 Insertion Inhibitor 15 | BLU-451 is a blood-brain-barrier penetrant, mutant-selective, EGFR inhibitor with activity against exon 20 insertions, which blocks downstream signaling potentially resulting in decreased tumor growth (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05241873 | Phase Ib/II | BLU-451 | (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations | Terminated | USA | CAN | 3 |